President Trump says he still intends to levy tariffs on semiconductors produced outside the US, despite TSMC (TSM) and other tech companies promising to invest billions in the country’s chip ...

Squamous cell cancer (SCC ... it can also occur in the mouth, airways, lungs, digestive tract, and urinary tract. As such, the exact symptoms and staging criteria can vary depending on the ...

placebo in combination with carboplatin and paclitaxel as first-line treatment of advanced squamous non-small cell lung cancer (sq-NSCLC) with negative driver genes. The results show that the 5-year ...

PostGraduate Program in Molecular and Cellular Biology, Department of Physiological Sciences − Pharmacology, Biomedical Institute, Federal University of the State of Rio de Janeiro, Rio de Janeiro ...

Background: Lung squamous cell carcinoma (LUSC) is a malignant disease associated with poor therapeutic responses and prognosis. Preliminary studies have shown that the dysregulation of long ...

Histopathologically, it was determined that in cisplatin-aggravated tongue tissue damage, filiform papillae decreased when ATP was administered, and the arrangement and structures of the epithelium ..

For those with squamous cell carcinoma of the lungs, anti-EGFR antibodies may be used. Clinical trials are also studying medications that address other genetic changes in lung cancer. Five ...

Purpose: This study aims to investigate the efficacy and safety of PD-1/PD-L1 inhibitors in the first-line treatment of esophageal squamous cell carcinoma (ESCC) and identify factors influencing ...

Advanced lung cancer, which has spread (metastasized) from the primary tumor to distant organs, is associated with lower survival rates. That's because lung cancer becomes more difficult to treat as ...